References
Adams, V. H., McBryant, S. J., Wade, P. A., Woodcock, C. L., & Hansen,
J. C. (2007). Intrinsic disorder and autonomous domain function in the
multifunctional nuclear protein, MeCP2. J Biol Chem, 282 (20),
15057-15064. doi:10.1074/jbc.M700855200
Adzhubei, I. A., Schmidt, S., Peshkin, L., Ramensky, V. E., Gerasimova,
A., Bork, P., . . . Sunyaev, S. R. (2010). A method and server for
predicting damaging missense mutations. Nat Methods, 7 (4),
248-249. doi:10.1038/nmeth0410-248
Amir, R. E., Van den Veyver, I. B., Schultz, R., Malicki, D. M., Tran,
C. Q., Dahle, E. J., . . . Zoghbi, H. Y. (2000). Influence of mutation
type and X chromosome inactivation on Rett syndrome phenotypes.Ann Neurol, 47 (5), 670-679.
Amir, R. E., Van den Veyver, I. B., Wan, M., Tran, C. Q., Francke, U.,
& Zoghbi, H. Y. (1999). Rett syndrome is caused by mutations in
X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet,
23 (2), 185-188. doi:10.1038/13810
Auranen, M., Vanhala, R., Vosman, M., Levander, M., Varilo, T., Hietala,
M., . . . Jarvela, I. (2001). MECP2 gene analysis in classical Rett
syndrome and in patients with Rett-like features. Neurology,
56 (5), 611-617. doi:10.1212/wnl.56.5.611
Ballestar, E., Ropero, S., Alaminos, M., Armstrong, J., Setien, F.,
Agrelo, R., . . . Esteller, M. (2005). The impact of MECP2 mutations in
the expression patterns of Rett syndrome patients. Hum Genet,
116 (1-2), 91-104. doi:10.1007/s00439-004-1200-0
Ballestar, E., Yusufzai, T. M., & Wolffe, A. P. (2000). Effects of Rett
syndrome mutations of the methyl-CpG binding domain of the
transcriptional repressor MeCP2 on selectivity for association with
methylated DNA. Biochemistry, 39 (24), 7100-7106.
Bedogni, F., Rossi, R. L., Galli, F., Cobolli Gigli, C., Gandaglia, A.,
Kilstrup-Nielsen, C., & Landsberger, N. (2014). Rett syndrome and the
urge of novel approaches to study MeCP2 functions and mechanisms of
action. Neurosci Biobehav Rev, 46 Pt 2 , 187-201.
doi:10.1016/j.neubiorev.2014.01.011
Bhanushali, A. A., Mandsaurwala, A., & Das, B. R. (2016). Homozygous
c.1160C>T (P38L) in the MECP2 gene in a female Rett
syndrome patient. J Clin Neurosci, 25 , 127-129.
doi:10.1016/j.jocn.2015.08.040
Bienvenu, T., Villard, L., De Roux, N., Bourdon, V., Fontes, M.,
Beldjord, C., . . . French Consortium for, M. G. A. (2002). Spectrum of
MECP2 mutations in Rett syndrome. Genet Test, 6 (1), 1-6.
doi:10.1089/109065702760093843
Bonino da Silva Santos, L. O., Wilkinson, M., Kuzniar, A.,
Kaliyaperumal, R., Thompson, M., Dumontier, M., & Burger, K. (2016).Enterprise Interoperability in the Digitized and Networked Factory
of the Future - FAIR Data Points Supporting Big Data Interoperability.(M. Zelm;, G. Doumeingts;, & J. P. Mendonça. Eds.): ISTE Press.
Cheadle, J. P., Gill, H., Fleming, N., Maynard, J., Kerr, A., Leonard,
H., . . . Clarke, A. (2000). Long-read sequence analysis of the MECP2
gene in Rett syndrome patients: correlation of disease severity with
mutation type and location. Hum Mol Genet, 9 (7), 1119-1129.
doi:10.1093/hmg/9.7.1119
Chen, R., Shi, L., Hakenberg, J., Naughton, B., Sklar, P., Zhang, J., .
. . Friend, S. H. (2016). Analysis of 589,306 genomes identifies
individuals resilient to severe Mendelian childhood diseases. Nat
Biotechnol, 34 (5), 531-538. doi:10.1038/nbt.3514
Christodoulou, J., Grimm, A., Maher, T., & Bennetts, B. (2003).
RettBASE: The IRSA MECP2 variation database-a new mutation database in
evolution. Hum Mutat, 21 (5), 466-472. doi:10.1002/humu.10194
Das, D. K., Raha, S., Sanghavi, D., Maitra, A., & Udani, V. (2013).
Spectrum of MECP2 gene mutations in a cohort of Indian patients with
Rett syndrome: report of two novel mutations. Gene, 515 (1),
78-83. doi:10.1016/j.gene.2012.11.024
Dong, C., Wei, P., Jian, X., Gibbs, R., Boerwinkle, E., Wang, K., &
Liu, X. (2015). Comparison and integration of deleteriousness prediction
methods for nonsynonymous SNVs in whole exome sequencing studies.Hum Mol Genet, 24 (8), 2125-2137. doi:10.1093/hmg/ddu733
Ebert, D. H., Gabel, H. W., Robinson, N. D., Kastan, N. R., Hu, L. S.,
Cohen, S., . . . Greenberg, M. E. (2013). Activity-dependent
phosphorylation of MeCP2 threonine 308 regulates interaction with NCoR.Nature, 499 (7458), 341-345. doi:10.1038/nature12348
Ehrhart, F., Coort, S. L., Cirillo, E., Smeets, E., Evelo, C. T., &
Curfs, L. M. (2016). Rett syndrome - biological pathways leading from
MECP2 to disorder phenotypes. Orphanet J Rare Dis, 11 (1), 158.
doi:10.1186/s13023-016-0545-5
Ehrhart, F., Coort, S. L., Eijssen, L., Cirillo, E., Smeets, E. E.,
Bahram Sangani, N., . . . Curfs, L. M. G. (2018). Integrated analysis of
human transcriptome data for Rett syndrome finds a network of involved
genes. bioRxiv . doi:10.1101/274258
Ehrhart, F., Sangani, N. B., & Curfs, L. M. G. (2018). Current
developments in the genetics of Rett and Rett-like syndrome. Curr
Opin Psychiatry, 31 (2), 103-108. doi:10.1097/YCO.0000000000000389
Firth, H. V., Richards, S. M., Bevan, A. P., Clayton, S., Corpas, M.,
Rajan, D., . . . Carter, N. P. (2009). DECIPHER: Database of Chromosomal
Imbalance and Phenotype in Humans Using Ensembl Resources. Am J
Hum Genet, 84 (4), 524-533. doi:10.1016/j.ajhg.2009.03.010
Fokkema, I. F., Taschner, P. E., Schaafsma, G. C., Celli, J., Laros, J.
F., & den Dunnen, J. T. (2011). LOVD v.2.0: the next generation in gene
variant databases. Hum Mutat, 32 (5), 557-563.
doi:10.1002/humu.21438
Ghosh, R. P., Horowitz-Scherer, R. A., Nikitina, T., Gierasch, L. M., &
Woodcock, C. L. (2008). Rett syndrome-causing mutations in human MeCP2
result in diverse structural changes that impact folding and DNA
interactions. J Biol Chem, 283 (29), 20523-20534.
doi:10.1074/jbc.M803021200
Heckman, L. D., Chahrour, M. H., & Zoghbi, H. Y. (2014). Rett-causing
mutations reveal two domains critical for MeCP2 function and for
toxicity in MECP2 duplication syndrome mice. Elife, 3 .
doi:10.7554/eLife.02676
Horst;, E. v. d., Kaliyaperumal;, R., Tatum;, Z., Thompson;, M.,
Schultes;, E., Mina;, E., . . . Hoen., P. A. C. t. (2015). Finding novel
associations across domains using linked data: a case study on genetic
variants disrupting transcription start sites. Proceedings of the
8th International Conference on Semantic Web Applications and Tools for
Life Sciences, 1546 .
Huppke, P., Laccone, F., Kramer, N., Engel, W., & Hanefeld, F. (2000).
Rett syndrome: analysis of MECP2 and clinical characterization of 31
patients. Hum Mol Genet, 9 (9), 1369-1375.
doi:10.1093/hmg/9.9.1369
Inui, K., Akagi, M., Ono, J., Tsukamoto, H., Shimono, K., Mano, T., . .
. Okada, S. (2001). Mutational analysis of MECP2 in Japanese patients
with atypical Rett syndrome. Brain Dev, 23 (4), 212-215.
doi:10.1016/s0387-7604(01)00197-8
Jacobsen, A., Kaliyaperumal, R., Bonino da Silva Santos, L., Mons, B.,
Schultes, E., Roos, M., & Thompson, M. (2020). A Generic Workflow for
the Data FAIRification Process Data Intelligence, 2 (1-2), 56-65.
doi:10.1162/dint_a_00028
Kircher, M., Witten, D. M., Jain, P., O’Roak, B. J., Cooper, G. M., &
Shendure, J. (2014). A general framework for estimating the relative
pathogenicity of human genetic variants. Nat Genet, 46 (3),
310-315. doi:10.1038/ng.2892
Krishnaraj, R., Ho, G., & Christodoulou, J. (2017). RettBASE: Rett
syndrome database update. Hum Mutat, 38 (8), 922-931.
doi:10.1002/humu.23263
Landrum, M. J., Lee, J. M., Benson, M., Brown, G., Chao, C.,
Chitipiralla, S., . . . Maglott, D. R. (2016). ClinVar: public archive
of interpretations of clinically relevant variants. Nucleic Acids
Res, 44 (D1), D862-868. doi:10.1093/nar/gkv1222
Laurvick, C. L., de Klerk, N., Bower, C., Christodoulou, J., Ravine, D.,
Ellaway, C., . . . Leonard, H. (2006). Rett syndrome in Australia: a
review of the epidemiology. J Pediatr, 148 (3), 347-352.
doi:10.1016/j.jpeds.2005.10.037
Lek, M., Karczewski, K. J., Minikel, E. V., Samocha, K. E., Banks, E.,
Fennell, T., . . . Exome Aggregation, C. (2016). Analysis of
protein-coding genetic variation in 60,706 humans. Nature,
536 (7616), 285-291. doi:10.1038/nature19057
Liu, X., Wu, C., Li, C., & Boerwinkle, E. (2016). dbNSFP v3.0: A
One-Stop Database of Functional Predictions and Annotations for Human
Nonsynonymous and Splice-Site SNVs. Hum Mutat, 37 (3), 235-241.
doi:10.1002/humu.22932
Liyanage, V. R., & Rastegar, M. (2014). Rett syndrome and MeCP2.Neuromolecular Med, 16 (2), 231-264. doi:10.1007/s12017-014-8295-9
Lombardi, L. M., Baker, S. A., & Zoghbi, H. Y. (2015). MECP2 disorders:
from the clinic to mice and back. J Clin Invest, 125 (8),
2914-2923. doi:10.1172/JCI78167
Lopes, F., Barbosa, M., Ameur, A., Soares, G., de Sa, J., Dias, A. I., .
. . Maciel, P. (2016). Identification of novel genetic causes of Rett
syndrome-like phenotypes. J Med Genet, 53 (3), 190-199.
doi:10.1136/jmedgenet-2015-103568
Lucariello, M., Vidal, E., Vidal, S., Saez, M., Roa, L., Huertas, D., .
. . Esteller, M. (2016). Whole exome sequencing of Rett syndrome-like
patients reveals the mutational diversity of the clinical phenotype.Hum Genet, 135 (12), 1343-1354. doi:10.1007/s00439-016-1721-3
McLaren, W., Gil, L., Hunt, S. E., Riat, H. S., Ritchie, G. R.,
Thormann, A., . . . Cunningham, F. (2016). The Ensembl Variant Effect
Predictor. Genome Biol, 17 (1), 122. doi:10.1186/s13059-016-0974-4
Nan, X., Ng, H. H., Johnson, C. A., Laherty, C. D., Turner, B. M.,
Eisenman, R. N., & Bird, A. (1998). Transcriptional repression by the
methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex.Nature, 393 (6683), 386-389. doi:10.1038/30764
Neul, J. L., Fang, P., Barrish, J., Lane, J., Caeg, E. B., Smith, E. O.,
. . . Glaze, D. G. (2008). Specific mutations in methyl-CpG-binding
protein 2 confer different severity in Rett syndrome. Neurology,
70 (16), 1313-1321. doi:10.1212/01.wnl.0000291011.54508.aa
Neul, J. L., Kaufmann, W. E., Glaze, D. G., Christodoulou, J., Clarke,
A. J., Bahi-Buisson, N., . . . RettSearch, C. (2010). Rett syndrome:
revised diagnostic criteria and nomenclature. Ann Neurol, 68 (6),
944-950. doi:10.1002/ana.22124
Nielsen, J. B., Henriksen, K. F., Hansen, C., Silahtaroglu, A.,
Schwartz, M., & Tommerup, N. (2001). MECP2 mutations in Danish patients
with Rett syndrome: high frequency of mutations but no consistent
correlations with clinical severity or with the X chromosome
inactivation pattern. Eur J Hum Genet, 9 (3), 178-184.
doi:10.1038/sj.ejhg.5200600
Percy, A. K., Lane, J. B., Childers, J., Skinner, S., Annese, F.,
Barrish, J., . . . MacLeod, P. (2007). Rett syndrome: North American
database. J Child Neurol, 22 (12), 1338-1341.
doi:10.1177/0883073807308715
Percy, A. K., Neul, J. L., Glaze, D. G., Motil, K. J., Skinner, S. A.,
Khwaja, O., . . . Barnes, K. (2010). Rett syndrome diagnostic criteria:
lessons from the Natural History Study. Ann Neurol, 68 (6),
951-955. doi:10.1002/ana.22154
Pizzo, L., Jensen, M., Polyak, A., Rosenfeld, J. A., Mannik, K.,
Krishnan, A., . . . Girirajan, S. (2018). Rare variants in the genetic
background modulate cognitive and developmental phenotypes in
individuals carrying disease-associated variants. Genet Med .
doi:10.1038/s41436-018-0266-3
Rett, A. (1966). [On a unusual brain atrophy syndrome in
hyperammonemia in childhood]. Wien Med Wochenschr, 116 (37),
723-726.
Sajan, S. A., Jhangiani, S. N., Muzny, D. M., Gibbs, R. A., Lupski, J.
R., Glaze, D. G., . . . Neul, J. L. (2017). Enrichment of mutations in
chromatin regulators in people with Rett syndrome lacking mutations in
MECP2. Genet Med, 19 (1), 13-19. doi:10.1038/gim.2016.42
Shannon, P., Markiel, A., Ozier, O., Baliga, N. S., Wang, J. T., Ramage,
D., . . . Ideker, T. (2003). Cytoscape: a software environment for
integrated models of biomolecular interaction networks. Genome
Res, 13 (11), 2498-2504. doi:10.1101/gr.1239303
Shihab, H. A., Rogers, M. F., Gough, J., Mort, M., Cooper, D. N., Day,
I. N., . . . Campbell, C. (2015). An integrative approach to predicting
the functional effects of non-coding and coding sequence variation.Bioinformatics, 31 (10), 1536-1543.
doi:10.1093/bioinformatics/btv009
Shovlin, S., & Tropea, D. (2018). Transcriptome level analysis in Rett
syndrome using human samples from different tissues. Orphanet J
Rare Dis, 13 (1), 113. doi:10.1186/s13023-018-0857-8
Sim, N. L., Kumar, P., Hu, J., Henikoff, S., Schneider, G., & Ng, P. C.
(2012). SIFT web server: predicting effects of amino acid substitutions
on proteins. Nucleic Acids Res, 40 (Web Server issue), W452-457.
doi:10.1093/nar/gks539
Tao, J., Hu, K., Chang, Q., Wu, H., Sherman, N. E., Martinowich, K., . .
. Sun, Y. E. (2009). Phosphorylation of MeCP2 at Serine 80 regulates its
chromatin association and neurological function. Proc Natl Acad
Sci U S A, 106 (12), 4882-4887. doi:10.1073/pnas.0811648106
Thompson, M., Burger, J., Kaliyaperumal, R., Roos, M., & Bonino da
Silva Santos, L. (2020). Making FAIR easy with FAIR tools: From
creolization to convergence. Data Intelligence, 2 , 87–95.
doi:10.1162/dint_a_00031
Tillotson, R., Selfridge, J., Koerner, M. V., Gadalla, K. K. E., Guy,
J., De Sousa, D., . . . Bird, A. (2017). Radically truncated MeCP2
rescues Rett syndrome-like neurological defects. Nature,
550 (7676), 398-401. doi:10.1038/nature24058
Townend, G. S., Ehrhart, F., van Kranen, H. J., Wilkinson, M., Jacobsen,
A., Roos, M., . . . Curfs, L. M. G. (2018). MECP2 variation in Rett
syndrome-An overview of current coverage of genetic and phenotype data
within existing databases. Hum Mutat, 39 (7), 914-924.
doi:10.1002/humu.23542
Vidal, S., Brandi, N., Pacheco, P., Gerotina, E., Blasco, L., Trotta, J.
R., . . . Rett Working, G. (2017). The utility of Next Generation
Sequencing for molecular diagnostics in Rett syndrome. Sci Rep,
7 (1), 12288. doi:10.1038/s41598-017-11620-3
Wan, M., Lee, S. S., Zhang, X., Houwink-Manville, I., Song, H. R., Amir,
R. E., . . . Francke, U. (1999). Rett syndrome and beyond: recurrent
spontaneous and familial MECP2 mutations at CpG hotspots. Am J Hum
Genet, 65 (6), 1520-1529. doi:10.1086/302690
Wang, J., Tang, J., Lai, M., & Zhang, H. (2014).
5-Hydroxymethylcytosine and disease. Mutat Res Rev Mutat Res,
762 , 167-175. doi:10.1016/j.mrrev.2014.09.003
Weaving, L. S., Williamson, S. L., Bennetts, B., Davis, M., Ellaway, C.
J., Leonard, H., . . . Christodoulou, J. (2003). Effects of MECP2
mutation type, location and X-inactivation in modulating Rett syndrome
phenotype. Am J Med Genet A, 118A (2), 103-114.
doi:10.1002/ajmg.a.10053
Wildeman, M., van Ophuizen, E., den Dunnen, J. T., & Taschner, P. E.
(2008). Improving sequence variant descriptions in mutation databases
and literature using the Mutalyzer sequence variation nomenclature
checker. Hum Mutat, 29 (1), 6-13. doi:10.1002/humu.20654
Zappella, M., Meloni, I., Longo, I., Hayek, G., & Renieri, A. (2001).
Preserved speech variants of the Rett syndrome: molecular and clinical
analysis. Am J Med Genet, 104 (1), 14-22. doi:10.1002/ajmg.10005